Although reactive hypoglycemia during OGTT was once considered a marker of CFRD risk due to underlying insulin dysregulation, recent studies have found no such association, with some even suggesting a lower risk [62–64]. This evidence concerns the gene INS and cystic fibrosis-related diabetes.